Study of Talimogene Laherparepvec In Children With Advanced Non CNS Tumors

NCT02756845 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Non CNS Tumors

Interventions

DRUG: Talimogene Laherparepvec

Sponsor

Amgen